|
|
Morgenthaler is a venture capital and buyout firm that has worked with entrepreneurs to build companies for more than 40 years. Today, the firm has nearly $3 billion under management, including $450 million in its ninth and current fund, MVP IX, capitalized in November of 2008. Morgenthaler is headquartered in CA, with offices in Boulder, CO; and Cleveland, OH. The Boston office engages in both Life Sciences Venture and Buyout activities. In 2012, Peter Taft, Karen Tuleta, Joe Machado and the rest of their team formed MPE Partners (“MPE†or “Morgenthaler Private Equityâ€). MPE Partners focuses on lower middle market leveraged buyouts, recapitalizations, and build up investments. MPE and Morgenthaler are separate and distinct entities and MPE is not an affiliate of Morgenthaler. All of the Private Equity investments made and managed by the Private Equity team in the Morgenthaler funds have been fully realized. The firm expects to invest between $5 and $15 million total in each information technology company, between $12 and $20 million in each biotech company, and between $12 and $15 million in each device company over several rounds. Initial investments can be as small as $500 thousand. Within information technology, Morgenthaler invests accross a broad spectrum of life sciences companies, particularly those in the fields of: Therapeutic Biopharmaceuticals and Medical Devices.
|
